Literature DB >> 3794408

Blood dapsone levels in leprosy patients treated with acedapsone.

J George, S Balakrishnan.   

Abstract

The metabolism of the repository drug acedapsone (DADDS,4,4'-diacetyldiaminodiphenyl sulfone) was studied in 15 individuals receiving 225 mg of DADDS, intramuscularly for a period of 75 days. Plasma levels of DDS were determined on the 2nd, 7th, 15th, 30th, 60th and 75th day after administration of the drug by spectrophoto-fluorometric technique. The mean peak levels of DDS (85.36 ng/ml) were noticed on 7th day followed by a gradual decrease in DDS concentration. The mean half-life level (44.53 ng/ml) of DDS were observed around the 15th day. The mean DDS level for the entire period of observation after one dose was 41.95 ng/ml. On the 75th day, the DDS level reached the minimum value of 14.76 ng/ml which was still about 5 times more than the minimal inhibitory concentration (MIC) level of DDS against M. leprae (3 ng/ml). The results are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3794408

Source DB:  PubMed          Journal:  Indian J Lepr        ISSN: 0254-9395


  2 in total

Review 1.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

2.  Antitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs.

Authors:  Parvati B Patel; Tejas K Patel; Seema N Baxi; Hemangini R Acharya; Chandrabhanu Tripathi
Journal:  J Pharmacol Pharmacother       Date:  2011-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.